USANA Health Sciences, Inc. (USNA) Earnings History
Earnings Pressure31 years of earnings data (1995–2025) · 5-year EPS trend is negative
Loading earnings history...
USANA Health Sciences, Inc. (USNA) Earnings Overview
As of June 22, 2026, USANA Health Sciences, Inc. (USNA) reported trailing twelve-month net income of $11M, reflecting -73.5% year-over-year growth. The company earned $0.59 per diluted share over the past four quarters, with a net profit margin of 1.2%.
Looking at the long-term picture, USNA's 5-year EPS compound annual growth rate (CAGR) stands at -37.0%, signaling declining earnings. The company achieved its highest annual net income of $126M in fiscal 2018.
USANA Health Sciences, Inc. maintains positive profitability with a gross margin of 78.3%, operating margin of 5.5%, and net margin of 1.2%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including NUS ($55M net income, 10.8% margin), NATR ($20M net income, 4.1% margin), NHTC (-$1M net income, -2.2% margin), USNA has room to improve margins relative to the peer group. Compare USNA vs NUS →
USNA Earnings vs Peers
Earnings metrics vs comparable public companies
USNA Historical Earnings Data (1995–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $11M | -74.4% | $51M | $0.58 | 1.2% | 5.5% |
| 2024 | $42M | -34.1% | $66M | $2.19 | 4.9% | 7.8% |
| 2023 | $64M | -8.0% | $93M | $3.30 | 6.9% | 10.1% |
| 2022 | $69M | -40.5% | $108M | $3.59 | 6.9% | 10.8% |
| 2021 | $117M | -6.5% | $170M | $5.73 | 9.8% | 14.3% |
| 2020 | $125M | +24.0% | $176M | $5.86 | 11.0% | 15.6% |
| 2019 | $101M | -20.4% | $146M | $4.41 | 9.5% | 13.8% |
| 2018 | $126M | +101.8% | $188M | $5.12 | 10.6% | 15.8% |
| 2017 | $63M | -37.5% | $133M | $2.53 | 6.0% | 12.7% |
| 2016 | $100M | +5.7% | $139M | $3.99 | 9.9% | 13.8% |
| 2015 | $95M | +23.5% | $142M | $3.59 | 10.3% | 15.4% |
| 2014 | $77M | -3.0% | $116M | $2.80 | 9.7% | 14.7% |
| 2013 | $79M | +19.0% | $117M | $2.78 | 11.0% | 16.3% |
| 2012 | $66M | +30.9% | $98M | $2.23 | 10.2% | 15.1% |
| 2011 | $51M | +11.2% | $77M | $1.63 | 8.7% | 13.3% |
| 2010 | $46M | +36.0% | $68M | $1.43 | 8.8% | 13.2% |
| 2009 | $34M | +12.1% | $51M | $1.09 | 7.7% | 11.6% |
| 2008 | $30M | -33.9% | $48M | $0.93 | 7.0% | 11.2% |
| 2007 | $45M | +9.8% | $71M | $1.32 | 10.7% | 16.7% |
| 2006 | $41M | +5.8% | $62M | $1.10 | 11.0% | 16.7% |
| 2005 | $39M | +26.7% | $58M | $0.99 | 11.9% | 17.8% |
| 2004 | $31M | +47.8% | $45M | $0.76 | 11.3% | 16.4% |
| 2003 | $21M | +144.8% | $31M | $0.49 | 10.4% | 15.6% |
| 2002 | $9M | +286.7% | $13M | $0.21 | 6.4% | 9.6% |
| 2001 | $2M | -23.3% | $4M | $0.06 | 1.9% | 3.7% |
| 2000 | $3M | -51.4% | $5M | $0.07 | 2.3% | 4.4% |
| 1999 | $6M | -37.9% | $14M | $0.12 | 4.6% | 10.8% |
| 1998 | $10M | +43.9% | $15M | $0.17 | 7.8% | 12.5% |
| 1997 | $7M | +32.0% | $11M | $0.12 | 7.7% | 12.4% |
| 1996 | $5M | +117.4% | $8M | $0.10 | 8.8% | 13.9% |
| 1995 | $2M | - | $4M | $0.05 | 9.4% | 14.3% |
Download Data
Export USNA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
USNA — Frequently Asked Questions
Quick answers to the most common questions about buying USNA stock.
What is USNA earnings per share (EPS)?
USNA trailing twelve-month (TTM) diluted EPS is $0.59, reflecting -73.5% year-over-year growth. The 5-year EPS CAGR is -37.0%. Complete EPS history from 1995 to 2025 is available in the table on this page.
What is USANA Health Sciences, Inc.'s net income?
USANA Health Sciences, Inc. (USNA) trailing twelve-month net income is $11M as of 2025. Earnings declined -73.5% year-over-year. USANA Health Sciences, Inc. has been profitable for 31 consecutive years.
Is USNA profitable?
Yes, USNA is profitable with a TTM net income of $11M and a net profit margin of +1.2%. USANA Health Sciences, Inc. has generated profits for 31 consecutive years.
What is USNA's earnings growth rate?
USNA compound annual EPS growth rates (CAGR): 1-Year: -73.5%, 3-Year: -45.5%, 5-Year: -37.0%, 10-Year: -16.7%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1995 to 2025.
What are USNA's profit margins?
USANA Health Sciences, Inc. net profit margin is +1.2%, operating margin is +5.5%, and gross margin is +78.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is +1.8%.
Is USNA growing earnings?
USNA earnings are declining — EPS fell -73.5% year-over-year. TTM net income dropped to $11M. This contrasts with the 5-year CAGR of -37.0%.
What was USNA's best earnings year?
USANA Health Sciences, Inc.'s highest annual net income on record is $126M, achieved in fiscal year 2018. Earnings history on this page spans 1995 to 2025 and includes all annual and quarterly figures.
What were USNA's earnings last quarter?
USNA's most recent reported quarter was Q4 2025. Net income was $-2M with diluted EPS of $-0.10. For a full breakdown of all quarters, see the quarterly earnings table on this page.